1. Home
  2. MXCT vs FLNT Comparison

MXCT vs FLNT Comparison

Compare MXCT & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.07

Market Cap

112.5M

Sector

Health Care

ML Signal

HOLD

Logo Fluent Inc.

FLNT

Fluent Inc.

HOLD

Current Price

$3.49

Market Cap

106.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
FLNT
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
112.5M
106.1M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
MXCT
FLNT
Price
$1.07
$3.49
Analyst Decision
Buy
Hold
Analyst Count
4
1
Target Price
$5.50
$3.50
AVG Volume (30 Days)
1.0M
14.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.67
EPS
N/A
N/A
Revenue
$33,026,000.00
$208,764,000.00
Revenue This Year
N/A
$5.89
Revenue Next Year
$18.50
$12.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$1.70
52 Week High
$2.19
$4.15

Technical Indicators

Market Signals
Indicator
MXCT
FLNT
Relative Strength Index (RSI) 36.81 49.54
Support Level $0.97 $3.39
Resistance Level $1.16 $3.52
Average True Range (ATR) 0.08 0.18
MACD -0.03 -0.05
Stochastic Oscillator 7.00 21.74

Price Performance

Historical Comparison
MXCT
FLNT

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About FLNT Fluent Inc.

Fluent Inc is a commerce media solutions provider that connects brands with engaged consumers by leveraging diverse advertising inventory, robust first-party data, and proprietary machine learning. The company mainly delivers customer acquisition services through scalable digital marketing campaigns, linking advertisers with targeted audiences. It reaches consumers through its Commerce Media Solutions, which integrate targeted advertising into e-commerce and digital media transaction flows on partner websites and mobile applications, as well as through its owned and operated digital media properties. The company operates in the United States, which generates the majority of its revenue, along with international markets.

Share on Social Networks: